12.48
price down icon0.79%   -0.10
after-market アフターアワーズ: 12.70 0.22 +1.76%
loading
前日終値:
$12.58
開ける:
$12.62
24時間の取引高:
294.95K
Relative Volume:
0.82
時価総額:
$463.59M
収益:
$11.88M
当期純損益:
$-162.08M
株価収益率:
-0.9997
EPS:
-12.484
ネットキャッシュフロー:
$-156.43M
1週間 パフォーマンス:
-11.61%
1か月 パフォーマンス:
-33.62%
6か月 パフォーマンス:
-37.44%
1年 パフォーマンス:
+10.54%
1日の値動き範囲:
Value
$12.31
$13.19
1週間の範囲:
Value
$12.18
$15.28
52週間の値動き範囲:
Value
$8.72
$27.41

Crescent Biopharma Inc Stock (CBIO) Company Profile

Name
名前
Crescent Biopharma Inc
Name
セクター
Healthcare (1051)
Name
電話
617-430-5595
Name
住所
300 FIFTH AVENUE, WALTHAM, CA
Name
職員
44
Name
Twitter
@catalystbio
Name
次回の収益日
2026-11-05
Name
最新のSEC提出書
Name
CBIO's Discussions on Twitter

Compare CBIO vs VRTX, MRNA, REGN, ARGX, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
CBIO icon
CBIO
Crescent Biopharma Inc
12.48 463.59M 11.88M -162.08M -156.43M -12.48
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
508.75 128.95B 12.34B 4.34B 3.71B 16.87
MRNA icon
MRNA
Moderna Inc
236.50 94.42B 2.23B -3.19B -1.60B -8.1462
REGN icon
REGN
Regeneron Pharmaceuticals Inc
796.34 81.99B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
846.27 53.22B 4.16B 1.29B 734.26M 19.58
ONC icon
ONC
Beone Medicines Ltd Adr
374.08 42.32B 5.76B 514.49M 1.10B 4.4813

Crescent Biopharma Inc Stock (CBIO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-10-06 アップグレード H.C. Wainwright Neutral → Buy
2026-06-01 ダウングレード H.C. Wainwright Buy → Neutral
2026-01-28 開始されました Piper Sandler Overweight
2026-01-21 開始されました Guggenheim Buy
2025-08-25 開始されました Jefferies Buy
2025-08-11 開始されました H.C. Wainwright Buy
2025-07-14 開始されました Wedbush Outperform
2025-06-25 開始されました Stifel Buy
2025-03-21 開始されました Cantor Fitzgerald Overweight
2025-03-11 開始されました Noble Capital Markets Outperform
2024-07-26 ダウングレード TD Cowen Buy → Hold
2023-12-22 開始されました CapitalOne Overweight
2021-11-12 アップグレード Jefferies Hold → Buy
2021-04-29 再開されました Stephens Overweight
2021-02-10 開始されました Piper Sandler Overweight
2020-05-21 開始されました Raymond James Outperform
2019-11-14 開始されました ROTH Capital Buy
2019-08-05 ダウングレード Jefferies Buy → Hold
2019-08-05 ダウングレード Piper Jaffray Overweight → Neutral
2019-08-05 ダウングレード SunTrust Buy → Hold
2019-04-12 開始されました Piper Jaffray Overweight
2019-01-04 開始されました Oppenheimer Outperform
2018-12-18 開始されました H.C. Wainwright Buy
2018-02-12 繰り返されました B. Riley FBR, Inc. Buy
2018-02-09 繰り返されました Chardan Capital Markets Buy
2017-12-08 開始されました B. Riley FBR, Inc. Buy
2017-06-12 開始されました Chardan Capital Markets Buy
2017-06-06 開始されました Ladenburg Thalmann Buy
2016-07-26 開始されました SunTrust Buy
2016-06-30 開始されました Rodman & Renshaw Buy
2015-03-17 繰り返されました Stifel Buy
すべてを表示

Crescent Biopharma Inc (CBIO) 最新ニュース

pulisher
Oct 05, 2026

Crescent Biopharma Announces FDA Clearance of IND for CR-002 and Plans Global Phase 1/2 APOLLO Trial in Advanced Solid Tumors - Quiver Quantitative

Oct 05, 2026
pulisher
Sep 25, 2026

Crescent Biopharma Announces Grants of Inducement Awards - Yahoo Finance

Sep 25, 2026
pulisher
Sep 21, 2026

Crescent Biopharma (Nasdaq:CBIO)Stock Analysis - Simply Wall Street

Sep 21, 2026
pulisher
Sep 17, 2026

BetterLife Pharma Raises $100 Million in a Public Offering of Shares and Warrants - Yahoo Finance

Sep 17, 2026
pulisher
Sep 16, 2026

Planned 804-share sale at Crescent Biopharma (Nasdaq: CBIO) - Stock Titan

Sep 16, 2026
pulisher
Sep 12, 2026

Certain Warrants of Crescent Biopharma, Inc. are subject to a Lock-Up Agreement Ending on 13-SEP-2026. - marketscreener.com

Sep 12, 2026
pulisher
Sep 12, 2026

Certain Options of Crescent Biopharma, Inc. are subject to a Lock-Up Agreement Ending on 13-SEP-2026. - marketscreener.com

Sep 12, 2026
pulisher
Sep 10, 2026

CBIO: Major clinical milestones and global expansion set for 2027, with key data and partnerships advancing - TradingView

Sep 10, 2026
pulisher
Sep 10, 2026

Crescent Biopharma at Cantor conference: global trial push By Investing.com - Investing.com Canada

Sep 10, 2026
pulisher
Sep 10, 2026

Crescent Biopharma at Cantor conference: global trial push - Investing.com India

Sep 10, 2026
pulisher
Sep 10, 2026

Crescent Biopharma at Cantor conference: global trial push - investing.com

Sep 10, 2026
pulisher
Sep 09, 2026

Two employees receive options tied to 58,650 Crescent Biopharma shares - Stock Titan

Sep 09, 2026
pulisher
Sep 09, 2026

Crescent Biopharma Announces Grants of Inducement Awards - Yahoo Finance

Sep 09, 2026
pulisher
Sep 03, 2026

Crescent Biopharma (CBIO) Surges 8.9% to $20.20 as Biotech Momentum BuildsIV Contraction - vinanet.vn

Sep 03, 2026
pulisher
Sep 03, 2026

Crescent Biopharma (CBIO) Surges 8.9% to $20.20 as Biotech Momentum BuildsTRIN Signal - siam.in

Sep 03, 2026
pulisher
Sep 03, 2026

Crescent Biopharma (CBIO) Surges 8.9% to $20.20 as Biotech Momentum BuildsStatistical Arbitrage - dars.gov.et

Sep 03, 2026
pulisher
Sep 03, 2026

Crescent Biopharma Announces September 2026 Investor Conference Presentations - quiverquant.com

Sep 03, 2026
pulisher
Sep 03, 2026

Crescent Biopharma to Present at September Investor Conferences - GlobeNewswire

Sep 03, 2026
pulisher
Sep 03, 2026

Crescent Biopharma to Present at September Investor Conferences - Yahoo Finance

Sep 03, 2026
pulisher
Sep 03, 2026

Crescent Capital (CCAP) holder sells at about $10.50 under trading plan - Stock Titan

Sep 03, 2026
pulisher
Aug 21, 2026

Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Aug 21, 2026
pulisher
Aug 20, 2026

Balyasny Asset Management L.P. Expands Stake in Crescent Biophar - GuruFocus

Aug 20, 2026
pulisher
Aug 17, 2026

Crescent Biopharma (NASDAQ:CBIO) Stock Price Up 4.9%Should You Buy? - MarketBeat

Aug 17, 2026
pulisher
Aug 14, 2026

Balyasny Asset Management (CBIO) discloses 6.03% Crescent Biopharma ownership - Stock Titan

Aug 14, 2026
pulisher
Aug 12, 2026

Crescent Biopharma (NASDAQ:CBIO) Shares Gap DownShould You Sell? - MarketBeat

Aug 12, 2026
pulisher
Aug 11, 2026

Crescent Biopharma (CBIO) Shares Dip 2.86% as Stock Approaches Key $16 Support LevelDay Trade Opportunities - vinanet.vn

Aug 11, 2026
pulisher
Aug 08, 2026

CBIO Q2 2026 Earnings: Narrower-Than-Expected Loss Buoys SharesRevenue Miss Report - vinanet.vn

Aug 08, 2026
pulisher
Aug 06, 2026

Crescent Biopharma Ord Shs (CBIO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 06, 2026
pulisher
Aug 05, 2026

Q3 EPS Forecast for Crescent Biopharma Lowered by Analyst - marketbeat.com

Aug 05, 2026
pulisher
Aug 04, 2026

Analysts Offer Insights on Healthcare Companies: Dyne Therapeutics (DYN) and Crescent Biopharma (CBIO) - The Globe and Mail

Aug 04, 2026
pulisher
Aug 03, 2026

Crescent Biopharma Announces Grants of Inducement Awards - The Manila Times

Aug 03, 2026
pulisher
Aug 03, 2026

Crescent Biopharma Announces Grants of Inducement Awards - GlobeNewswire

Aug 03, 2026
pulisher
Aug 03, 2026

CRESCENT BIOPHARMA, INC. SEC Filing (Aug 3, 2026) - Stock Titan

Aug 03, 2026
pulisher
Aug 02, 2026

Perceptive Advisors LLC Lowers Stake in Crescent Biopharma, Inc. $CBIO - MarketBeat

Aug 02, 2026
pulisher
Aug 01, 2026

Crescent Biopharma (CBIO) Gets a Buy from Wedbush - The Globe and Mail

Aug 01, 2026
pulisher
Jul 30, 2026

Crescent Biopharma Announces Q2 2026 Financial Results and Operational Update - Kalkine Media

Jul 30, 2026
pulisher
Jul 30, 2026

Crescent Biopharma Reports Q2 2026 Results and Advances Clinical Development of CR-001, CR-002 and CR-003 - Quiver Quantitative

Jul 30, 2026
pulisher
Jul 30, 2026

Crescent Biopharma: Q2 Earnings Snapshot - KING5.com

Jul 30, 2026
pulisher
Jul 30, 2026

Crescent Biopharma posts $24.8 million Q2 net loss - Quiver Quantitative

Jul 30, 2026
pulisher
Jul 30, 2026

Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewswire

Jul 30, 2026
pulisher
Jul 30, 2026

Crescent Biopharma posts $24.8 million Q2 net loss - quiverquant.com

Jul 30, 2026
pulisher
Jul 28, 2026

CBIO Q1 2026 Earnings: EPS Beat Despite Pre-Revenue Status; Stock DeclinesEPS Guidance Update - vinanet.vn

Jul 28, 2026
pulisher
Jul 27, 2026

Crescent Biopharma Ord Shs (CBIO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Crescent Biopharma Ord Shs (CBIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Crescent Biopharma Market Sentiment - Benzinga España

Jul 27, 2026
pulisher
Jul 27, 2026

Crescent Biopharma, Inc. (NASDAQ:CBIO) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

Jul 27, 2026
pulisher
Jul 27, 2026

Crescent Biopharma Ord Shs (CBIO) Institutional Confidence - TradingKey

Jul 27, 2026
pulisher
Jul 26, 2026

CBIO Q1 2026 Earnings: Narrower Loss Surprises Analysts as Cash Management ImprovesEarnings Quality Score - vinanet.vn

Jul 26, 2026
pulisher
Jul 25, 2026

CBIO|Crescent Biopharma Ord Shs|Price:16.300|Chg%:-0.730 - TradingKey

Jul 25, 2026
pulisher
Jul 24, 2026

Crescent Biopharma (CBIO) Shares Dip 4.3% as Stock Pulls Back Toward Key SupportDefined Outcome ETF - dars.gov.et

Jul 24, 2026

Crescent Biopharma Inc (CBIO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Crescent Biopharma Inc (CBIO) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Joshua T Brumm
Officer
Sep 18 '26
Proposed Sale
17.18
9,013
154,843
0
Jonathan McNeill
Officer
Sep 18 '26
Proposed Sale
17.18
4,415
75,850
0
McNeill Jonathan
President and COO
Sep 18 '26
Sale
16.71
3,839
64,150
134,588
Brumm Joshua T
Chief Executive Officer
Sep 18 '26
Sale
16.71
7,837
130,956
271,765
Brumm Joshua T
Chief Executive Officer
Sep 16 '26
Sale
17.90
1,610
28,819
279,602
McNeill Jonathan
President and COO
Sep 16 '26
Sale
17.90
731
13,085
138,427
Jonathan McNeill
Officer
Sep 16 '26
Proposed Sale
18.80
804
15,115
0
Joshua T Brumm
Officer
Sep 16 '26
Proposed Sale
18.80
1,771
33,295
0
Pinkas Jan
Chief Scientific Officer
Sep 16 '26
Sale
17.90
658
11,778
21,581
Im Ellie Eunkyung
Chief Medical Officer
Sep 16 '26
Sale
17.90
623
11,152
21,446
$7.50
price up icon 1.35%
$10.27
price up icon 0.39%
$5.74
price up icon 5.03%
$18.93
price up icon 5.17%
$10.91
price up icon 6.03%
WVE WVE
$3.19
price up icon 3.24%
大文字化:     |  ボリューム (24 時間):